Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05335720Not ApplicableCompleted

Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)

Role: lead

NCT05422755Completed

The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients

Role: lead

NCT05373303Not ApplicableCompleted

The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®

Role: lead

All 3 trials loaded